BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20215580)

  • 1. A novel role for ABCA1-generated large pre-beta migrating nascent HDL in the regulation of hepatic VLDL triglyceride secretion.
    Chung S; Gebre AK; Seo J; Shelness GS; Parks JS
    J Lipid Res; 2010 Apr; 51(4):729-42. PubMed ID: 20215580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic ABCA1 and VLDL triglyceride production.
    Liu M; Chung S; Shelness GS; Parks JS
    Biochim Biophys Acta; 2012 May; 1821(5):770-7. PubMed ID: 22001232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic ABCA1 deficiency is associated with delayed apolipoprotein B secretory trafficking and augmented VLDL triglyceride secretion.
    Liu M; Chung S; Shelness GS; Parks JS
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Oct; 1862(10 Pt A):1035-1043. PubMed ID: 28694219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted deletion of hepatocyte ABCA1 leads to very low density lipoprotein triglyceride overproduction and low density lipoprotein hypercatabolism.
    Chung S; Timmins JM; Duong M; Degirolamo C; Rong S; Sawyer JK; Singaraja RR; Hayden MR; Maeda N; Rudel LL; Shelness GS; Parks JS
    J Biol Chem; 2010 Apr; 285(16):12197-209. PubMed ID: 20178985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATP-Binding Cassette Transporter A1 Deficiency in Human Induced Pluripotent Stem Cell-Derived Hepatocytes Abrogates HDL Biogenesis and Enhances Triglyceride Secretion.
    Bi X; Pashos EE; Cuchel M; Lyssenko NN; Hernandez M; Picataggi A; McParland J; Yang W; Liu Y; Yan R; Yu C; DerOhannessian SL; Phillips MC; Morrisey EE; Duncan SA; Rader DJ
    EBioMedicine; 2017 Apr; 18():139-145. PubMed ID: 28330813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABCA1-dependent lipid efflux to apolipoprotein A-I mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes.
    Sahoo D; Trischuk TC; Chan T; Drover VA; Ho S; Chimini G; Agellon LB; Agnihotri R; Francis GA; Lehner R
    J Lipid Res; 2004 Jun; 45(6):1122-31. PubMed ID: 14993246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic ABC transporters and triglyceride metabolism.
    Parks JS; Chung S; Shelness GS
    Curr Opin Lipidol; 2012 Jun; 23(3):196-200. PubMed ID: 22488425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
    Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
    Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an ABCA1-dependent phospholipid-rich plasma membrane apolipoprotein A-I binding site for nascent HDL formation: implications for current models of HDL biogenesis.
    Hassan HH; Denis M; Lee DY; Iatan I; Nyholt D; Ruel I; Krimbou L; Genest J
    J Lipid Res; 2007 Nov; 48(11):2428-42. PubMed ID: 17656736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP-binding cassette transporter AI and its role in HDL formation.
    Lee JY; Parks JS
    Curr Opin Lipidol; 2005 Feb; 16(1):19-25. PubMed ID: 15650559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipose tissue ATP binding cassette transporter A1 contributes to high-density lipoprotein biogenesis in vivo.
    Chung S; Sawyer JK; Gebre AK; Maeda N; Parks JS
    Circulation; 2011 Oct; 124(15):1663-72. PubMed ID: 21931081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors controlling nascent high-density lipoprotein particle heterogeneity: ATP-binding cassette transporter A1 activity and cell lipid and apolipoprotein AI availability.
    Lyssenko NN; Nickel M; Tang C; Phillips MC
    FASEB J; 2013 Jul; 27(7):2880-92. PubMed ID: 23543682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal lipidation of pre-beta HDL by ABCA1 results in reduced ability to interact with ABCA1.
    Mulya A; Lee JY; Gebre AK; Thomas MJ; Colvin PL; Parks JS
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1828-36. PubMed ID: 17510466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro.
    Hafiane A; Bielicki JK; Johansson JO; Genest J
    PLoS One; 2015; 10(7):e0131997. PubMed ID: 26207756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial interaction of apoA-I with ABCA1 impacts in vivo metabolic fate of nascent HDL.
    Mulya A; Lee JY; Gebre AK; Boudyguina EY; Chung SK; Smith TL; Colvin PL; Jiang XC; Parks JS
    J Lipid Res; 2008 Nov; 49(11):2390-401. PubMed ID: 18583707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein M expression increases the size of nascent pre beta HDL formed by ATP binding cassette transporter A1.
    Mulya A; Seo J; Brown AL; Gebre AK; Boudyguina E; Shelness GS; Parks JS
    J Lipid Res; 2010 Mar; 51(3):514-24. PubMed ID: 19767535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.
    Timmins JM; Lee JY; Boudyguina E; Kluckman KD; Brunham LR; Mulya A; Gebre AK; Coutinho JM; Colvin PL; Smith TL; Hayden MR; Maeda N; Parks JS
    J Clin Invest; 2005 May; 115(5):1333-42. PubMed ID: 15841208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABCA1 and metabolic syndrome; a review of the ABCA1 role in HDL-VLDL production, insulin-glucose homeostasis, inflammation and obesity.
    Babashamsi MM; Koukhaloo SZ; Halalkhor S; Salimi A; Babashamsi M
    Diabetes Metab Syndr; 2019; 13(2):1529-1534. PubMed ID: 31336517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin deficiency suppresses ABCA1 expression and ApoA-I synthesis in the liver.
    Oku H; Matsuura F; Koseki M; Sandoval JC; Yuasa-Kawase M; Tsubakio-Yamamoto K; Masuda D; Maeda N; Ohama T; Ishigami M; Nishida M; Hirano K; Kihara S; Hori M; Shimomura I; Yamashita S
    FEBS Lett; 2007 Oct; 581(26):5029-33. PubMed ID: 17936760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.